Topics

Boehringer Ingelheim, Bridge Biotherapeutics to Collaborate on IPF Pipeline

05:46 EDT 23 Jul 2019 | Contract Pharma

Global license agreement aims to develop Bridge Biotherapeutics’ autotaxin inhibitor, BBT-877

Original Article: Boehringer Ingelheim, Bridge Biotherapeutics to Collaborate on IPF Pipeline

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim, Bridge Biotherapeutics to Collaborate on IPF Pipeline"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...